Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2011

01-03-2011 | Translational Research and Biomarkers

Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery

Authors: Louis A. Aliperti, Jarrod D. Predina, Anil Vachani, Sunil Singhal

Published in: Annals of Surgical Oncology | Issue 3/2011

Login to get access

Excerpt

This year approximately 569,490 Americans, more than 1,500 people per day, are expected to die of cancer. Cancer has supplanted heart disease as the leading cause of death in the United States in men and women younger than age 85 years (American Cancer Society, Facts and Figures 2010). Cancer also has a major economic impact on the U.S. economy, with 2010 estimates of cancer associated costs of $263.8 billion (American Cancer Society, Facts and Figures 2010). The four most common cancers (lung, colorectal, prostate, and breast cancer) account for more than half of all cancer incidences in the United States. Surgery, chemotherapy, and radiotherapy are the most established therapies for patients with these malignancies (American Cancer Society, Facts and Figures 2010). Surgery continues to be the most effective therapy for cancer in the United States. It is several-fold more effective than chemotherapy and radiation in curing patients with cancer. Unfortunately, many people are not surgical candidates due to advanced stage disease or comorbid conditions. …
Literature
1.
go back to reference Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent non-small-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–17; discussion 417–8. Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent non-small-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–17; discussion 417–8.
2.
go back to reference Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218–27.PubMedCrossRef Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218–27.PubMedCrossRef
3.
go back to reference Tsikitis VL, Malireddy K, Green EA, et al. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;27(22):3671–6.PubMedCrossRef Tsikitis VL, Malireddy K, Green EA, et al. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;27(22):3671–6.PubMedCrossRef
4.
go back to reference Guyot F, Faivre J, Manfredi S, et al. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16(5):756–61.PubMedCrossRef Guyot F, Faivre J, Manfredi S, et al. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16(5):756–61.PubMedCrossRef
5.
go back to reference Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684–91. Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684–91.
6.
go back to reference Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer. 2004;100(1):44–52.PubMedCrossRef Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer. 2004;100(1):44–52.PubMedCrossRef
7.
go back to reference Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. Eur J Surg Oncol. 2007;33(4):420–3.PubMedCrossRef Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. Eur J Surg Oncol. 2007;33(4):420–3.PubMedCrossRef
8.
go back to reference Agarwal PK, Sadetsky N, Konety BR, et al. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008;112(2):307–14.PubMedCrossRef Agarwal PK, Sadetsky N, Konety BR, et al. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008;112(2):307–14.PubMedCrossRef
9.
go back to reference Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433–9.PubMedCrossRef Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433–9.PubMedCrossRef
10.
go back to reference Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10(8):972–92.PubMedCrossRef Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10(8):972–92.PubMedCrossRef
Metadata
Title
Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery
Authors
Louis A. Aliperti
Jarrod D. Predina
Anil Vachani
Sunil Singhal
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1442-0

Other articles of this Issue 3/2011

Annals of Surgical Oncology 3/2011 Go to the issue